GENEVA, Aug. 10 -- SHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD. (Building 6, No. 518, Haoye RoadJinshan District, Shanghai 201506), 上海鑫湾生物科技有限公司 (中国上海市金山区豪业路518号6幢) filed a patent application (PCT/CN2025/072939) for "RECOMBINANT ONCOLYTIC ADENOVIRUS HAVING DUAL TUMOR TARGETING PROPERTIES, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Jan 17, 2025. With publication no. WO/2025/161993, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which...